We are live on ! Find out more
NEO icon

NeoGenomics

58 hedge funds and large institutions have $55.3M invested in NeoGenomics in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

4% more funds holding

Funds holding: 5658 (+2)

6% less capital invested

Capital invested by funds: $59M → $55.3M (-$3.79M)

Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
1.87%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
21
Reduced
13
Closed
11
Calls
Puts
Net Calls
Net Calls Change

NEO Hedge Fund Activity: Q3 2013 in Review

58 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2013, worth a combined $55.3M — down 6.4% from $59M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NEO positions and 11 closed out — a net gain of 3 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $5.74M. The largest seller was Essex Investment Management, exiting entirely with an estimated $1.7M sold.

  • 58 institutional investors held NeoGenomics (NEO) as of Q3 2013, up from 56 in Q2 2013.
  • Funds reported $55.3M of NeoGenomics stock for Q3 2013, down 6.4% quarter-over-quarter.
  • 14 funds opened new NeoGenomics positions in Q3 2013 and 11 closed out, a net change of +3 holders.
  • The largest NeoGenomics buyer in Q3 2013 was Wellington Management Group, an estimated $5.74M added.
  • The largest NeoGenomics seller in Q3 2013 was Essex Investment Management, an estimated $1.7M sold.

Based on aggregated 13F filings for Q3 2013.